23 Apr R&D and UK operational update

Posted at 07:00h in Board, Novacyt Group, Products by

Paris, France and Camberley, UK – 23 April 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on the progress of its near-term COVID-19 research and development (R&D) programmes to address rapidly evolving testing demands, particularly as SARS-CoV-2 continues to mutate around the world. Novacyt also provides an update on its UK operations.

https://novacyt.com/wp-content/uploads/2021/04/Novacyt-RD-Update-ENGLISH-Final-23.04.21.pdf